Yes, semaglutide can cause vomiting , and this is a well-documented adverse effect supported by extensive clinical trial data and post-marketing surveillance
Once injected, the medication reaches peak concentration within 13 days and maintains steady levels throughout the week
As of 2025, the shortage is resolved, but patients and prescribers may still see intermittent disruptions in supply
In addition to weight loss, tirzepatide and semaglutide can enhance insulin sensitivity, lower blood sugar levels, and reduce the risk of cardiovascular disease
Who Should Consider Alternative Formulations or Dosing Strategies Patients with a history of severe nausea, vomiting disorders (like cyclic vomiting syndrome), concurrent gastrointestinal conditions (GERD, gastroparesis), or those taking medications that increase nausea risk may benefit from slower escalation protocols or alternative GLP-1 agents
Retrieved from Gudin, B., Ladhari, C., Robin, P., et al